Shareholder alert: weiss law investigates albireo pharma, inc.

New york , jan. 9, 2023 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of albireo pharma, inc. ("albireo" or the "company") (nasdaq: albo), in connection with the proposed acquisition of the company by ipsen s.a. (otc: ipsey) via tender offer.

ALBO Ratings Summary

ALBO Quant Ranking